Impaired remyelination in late-onset multiple sclerosis.

In contrast, in late active lesions, where demyelination is more advanced, the number of BCAS1-positive oligodendrocytes was lower in the lesions of LOMS compared to NOMS patients, but these differences did not reach statistical significance (median LOMS 21.2 vs NOMS 33.2 cells/mm 2 , p = 0.6, Fig. 3 e).

also in 111,027 other papers